TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 90 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $491,992 | +81.4% | 11,620 | +79.0% | 0.00% | – |
Q4 2023 | $271,153 | +30.9% | 6,490 | +18.1% | 0.00% | – |
Q3 2023 | $207,179 | -100.0% | 5,494 | -35.2% | 0.00% | – |
Q4 2021 | $425,083,000 | -26.0% | 8,483 | -6.1% | 0.00% | – |
Q3 2021 | $574,706,000 | +186.2% | 9,032 | +223.6% | 0.00% | – |
Q2 2021 | $200,840,000 | -45.0% | 2,791 | -43.6% | 0.00% | – |
Q1 2021 | $365,063,000 | +24.4% | 4,950 | +23.8% | 0.00% | – |
Q4 2020 | $293,460,000 | -86.5% | 3,997 | -79.3% | 0.00% | -100.0% |
Q3 2017 | $2,178,298,000 | +0.7% | 19,330 | +0.2% | 0.00% | 0.0% |
Q2 2017 | $2,162,310,000 | -3.7% | 19,296 | +0.2% | 0.00% | 0.0% |
Q1 2017 | $2,245,752,000 | +148723.9% | 19,257 | +34.3% | 0.00% | 0.0% |
Q4 2016 | $1,509,000 | -30.7% | 14,335 | -27.3% | 0.00% | 0.0% |
Q3 2016 | $2,179,000 | +4.9% | 19,719 | +38.1% | 0.00% | 0.0% |
Q2 2016 | $2,078,000 | +350.8% | 14,274 | +343.2% | 0.00% | +100.0% |
Q1 2016 | $461,000 | -4.4% | 3,221 | +3.2% | 0.00% | 0.0% |
Q4 2015 | $482,000 | – | 3,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 650,089 | $27,954 | 12.84% |
Analyst IMS Investment Management Services Ltd. | 13,557 | $583 | 0.02% |
LRI Investments, LLC | 2,000 | $85,778 | 0.01% |
Gladius Capital Management LP | 761 | $32,701 | 0.00% |
RHUMBLINE ADVISERS | 12,625 | $542,490 | 0.00% |
Lindbrook Capital, LLC | 142 | $6,102 | 0.00% |
Covestor Ltd | 26 | $1 | 0.00% |
Red Tortoise LLC | 40 | $1,719 | 0.00% |
OSAIC HOLDINGS, INC. | 199 | $8,551 | 0.00% |
Parallel Advisors, LLC | 19 | $816 | 0.00% |